Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status
Aim: To examine benefits of corticosteroids for Duchenne muscular dystrophy (DMD) by age and disease progression. Methods: Data from daily steroid users (placebo-treated) were pooled from four phase 2b/3 trials in DMD. Outcomes assessed overall and among subgroups included changes from baseline to...
Main Authors: | Craig M McDonald, Jessica R Marden, Perry B Shieh, Brenda L Wong, Henry Lane, Adina Zhang, Ha Nguyen, Molly Frean, Panayiota Trifillis, Karyn Koladicz, James Signorovitch |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2023-02-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |
Similar Items
-
Growth pattern trajectories in boys with Duchenne muscular dystrophy
by: Georgia Stimpson, et al.
Published: (2022-01-01) -
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
by: Shefa Tawalbeh, et al.
Published: (2020-10-01) -
Influence of Different Types of Corticosteroids on Heart Rate Variability of Individuals with Duchenne Muscular Dystrophy—A Pilot Cross Sectional Study
by: Rodrigo Martins Dias, et al.
Published: (2021-07-01) -
Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications
by: Eugenio Mercuri, et al.
Published: (2023-11-01) -
Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients
by: Tsubasa Kameyama, et al.
Published: (2018-12-01)